Analysts Set Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Price Target at $13.27

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) have been given a consensus recommendation of “Reduce” by the fifteen research firms that are currently covering the stock, Marketbeat.com reports. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $13.27.

Several equities analysts have commented on the company. Evercore ISI upped their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. UBS Group upped their price target on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. Barclays raised their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 16th. Bank of America boosted their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Finally, Royal Bank of Canada raised their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th.

Walgreens Boots Alliance Price Performance

Walgreens Boots Alliance stock opened at $11.74 on Tuesday. Walgreens Boots Alliance has a 12-month low of $8.08 and a 12-month high of $23.76. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The firm has a 50-day moving average price of $9.73 and a 200-day moving average price of $9.86. The firm has a market capitalization of $10.15 billion, a PE ratio of -1.15, a price-to-earnings-growth ratio of 1.43 and a beta of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.66 earnings per share. As a group, equities research analysts forecast that Walgreens Boots Alliance will post 1.59 EPS for the current year.

Institutional Trading of Walgreens Boots Alliance

Institutional investors have recently modified their holdings of the company. Brooklyn Investment Group increased its position in Walgreens Boots Alliance by 21.1% during the 4th quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock valued at $44,000 after buying an additional 830 shares in the last quarter. First Financial Corp IN increased its holdings in shares of Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 885 shares in the last quarter. Sequoia Financial Advisors LLC increased its holdings in shares of Walgreens Boots Alliance by 4.4% during the third quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock valued at $226,000 after acquiring an additional 1,063 shares in the last quarter. Lincluden Management Ltd. raised its position in shares of Walgreens Boots Alliance by 0.4% in the 3rd quarter. Lincluden Management Ltd. now owns 264,644 shares of the pharmacy operator’s stock valued at $2,371,000 after purchasing an additional 1,074 shares during the last quarter. Finally, CWA Asset Management Group LLC boosted its stake in Walgreens Boots Alliance by 9.2% in the 4th quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock worth $120,000 after purchasing an additional 1,084 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.